Ms. Suvari joined GBT in October 2016 as chief legal officer with extensive experience in the life sciences industry. Previously, she served in several senior roles at CV Therapeutics, Inc., which was acquired by Gilead Sciences, Inc., ultimately as senior vice president, general counsel and chief compliance officer. In that position, she led the in-house legal team as the company transitioned from an R&D-stage to a commercial-stage company with marketed products in the United States and EU and multiple partnering arrangements. Prior to CV Therapeutics, she served as corporate counsel at Genentech, Inc., in increasingly senior roles where she completed many complex business development and licensing transactions and advised on legal compliance for several commercial products. Before joining GBT, Ms. Suvari served as a vice president and general counsel at the nonprofit Peninsula Open Space Trust. She also served as an independent consultant supporting early-stage private and public biopharmaceutical companies. Ms. Suvari earned a B.S. in geology and geophysics from Yale University and a J.D. from Harvard Law School.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
You are now leaving the Global Blood Therapeutics website
You are currently leaving our site. External links are being provided as a convenience and for informational purposes only; they do not constitute an endorsement or an approval by Global Blood Therapeutics. Are you sure you want to proceed?